Immunosuppressive therapy with rituximab in common variable immunodeficiency

Common variable immunodeficiency (CVID) is the most frequent symptomatic primary antibody deficiency in adulthood and is characterized by the marked reduction of IgG and IgA serum levels. Thanks to the successful use of polyvalent immunoglobulin replacement therapy to treat and prevent recurrent inf...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Mol Allergy
Autores principales: Pecoraro, Antonio, Crescenzi, Ludovica, Galdiero, Maria Rosaria, Marone, Giancarlo, Rivellese, Felice, Rossi, Francesca Wanda, de Paulis, Amato, Genovese, Arturo, Spadaro, Giuseppe
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501382/
https://ncbi.nlm.nih.gov/pubmed/31080365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-019-0113-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares